Related Experiment Video
Updated: Jul 17, 2026

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
Published on: February 18, 2022
[Congestive heart failure--etiology and diagnostic procedures]
Marit Aarønaes1, Dan Atar, Vernon Bonarjee
1Hjertemedisinsk avdeling, Rikshospitalet, 0027 Oslo. marit.aarones@rikshospitalet.no
Congestive heart failure (CHF) is a growing concern, especially in the elderly. This article proposes diagnostic guidelines for CHF, emphasizing history, risk factors, and key tests like B-type natriuretic peptide (BNP) measurements.
Area of Science:
- Cardiology
- Public Health
Context:
- Congestive heart failure (CHF) is a significant and increasing health issue globally, particularly affecting the elderly population.
- The prevalence of CHF presents diagnostic and therapeutic challenges for healthcare providers.
Purpose:
- To outline proposed guidelines for the etiology and diagnosis of congestive heart failure.
- To provide a framework for primary, secondary, and tertiary healthcare providers in Norway.
Summary:
- Hypertension and coronary artery disease are the primary causes of CHF, accounting for 75-80% of cases.
- Diagnostic evaluation includes thorough patient history, risk factor assessment, laboratory tests (including B-type natriuretic peptide - BNP), electrocardiograms, and chest X-rays.
- Echocardiography is recommended for suspected impaired left ventricular ejection fraction; invasive and advanced non-invasive imaging are reserved for select patients.
Impact:
- Aims to standardize CHF diagnosis and management across different healthcare levels.
- Facilitates early and accurate identification of CHF, potentially improving patient outcomes.
- Provides evidence-based recommendations for healthcare professionals dealing with increasing CHF prevalence.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies